Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Mori

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Cellular Neuroscience|October 25, 2021
Old Stars and New Players in the Brain Tumor MicroenvironmentElena Parmigiani, Marta Scalera, Elisabetta Mori, et al.
Toxins|April 3, 2021
CTX-CNF1 Recombinant Protein Selectively Targets Glioma Cells In VivoEleonora Vannini, Elisabetta Mori, Elena Tantillo, et al.
Neurobiology of Disease|June 9, 2025
Inhibitory circuit dysfunction as a potential contributor to cortical reorganization in Glioblastoma progressionCristina Spalletti, Marta Scalera, Elisabetta Mori, et al.
Journal of Translational Medicine|May 30, 2026
A brain-penetrant chimeric protein combines direct glioma targeting with myeloid cell-mediated immune reprogrammingElisabetta Mori, Elisa De Santis, Marta Scalera, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Cellular Neuroscience|October 25, 2021
Old Stars and New Players in the Brain Tumor MicroenvironmentElena Parmigiani, Marta Scalera, Elisabetta Mori, et al.
Toxins|April 3, 2021
CTX-CNF1 Recombinant Protein Selectively Targets Glioma Cells In VivoEleonora Vannini, Elisabetta Mori, Elena Tantillo, et al.
Neurobiology of Disease|June 9, 2025
Inhibitory circuit dysfunction as a potential contributor to cortical reorganization in Glioblastoma progressionCristina Spalletti, Marta Scalera, Elisabetta Mori, et al.
Journal of Translational Medicine|May 30, 2026
A brain-penetrant chimeric protein combines direct glioma targeting with myeloid cell-mediated immune reprogrammingElisabetta Mori, Elisa De Santis, Marta Scalera, et al.
Pageof 1